Hormone receptors and ovarian cancer survival
Menée à partir des données de 12 études incluant au total 2 933 patientes atteintes d'un cancer épithélial invasif de l'ovaire, cette étude évalue, en fonction du type de cancer (carcinome séreux, mucineux, endométrioïde ou à cellules claires), l'association entre le niveau d'expression tumorale du récepteur à la progestérone ou du récepteur aux estrogènes et la survie des patientes
The five main histological subtypes of epithelial ovarian cancer—high-grade serous carcinoma, low-grade serous carcinoma, endometrioid carcinoma, clear-cell carcinoma, and mucinous carcinoma—all differ in terms of age and stage of presentation, prognosis, driver genetic mutations, chemosensitivity, and even tissue of origin. 1 In almost all historical studies on which clinical practice is based (including many of the landmark clinical trials), ovarian cancer has been treated as one disease entity. ...
The Lancet Oncology , commentaire, 2012